Paloma Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,593
| Closed | -$17K | – | 1360 |
|
|
2018
Q4 | $17K | Buy |
+5,593
| New | +$17K | ﹤0.01% | 950 |
|
|
2018
Q3 | – | Sell |
-42,720
| Closed | -$323K | – | 1260 |
|
|
2018
Q2 | $323K | Buy |
42,720
+41,937
| +5,356% | +$317K | 0.01% | 945 |
|
|
2018
Q1 | $27K | Buy |
+783
| New | +$27K | ﹤0.01% | 1373 |
|
|
2017
Q4 | – | Sell |
-1,057
| Closed | -$45K | – | 1307 |
|
|
2017
Q3 | $45K | Buy |
+1,057
| New | +$45K | ﹤0.01% | 1452 |
|
|
2017
Q1 | – | Sell |
-688
| Closed | -$37K | – | 1498 |
|
|
2016
Q4 | $37K | Buy |
+688
| New | +$37K | ﹤0.01% | 1478 |
|
|
2016
Q3 | – | Sell |
-1,851
| Closed | -$122K | – | 1398 |
|
|
2016
Q2 | $122K | Sell |
1,851
-2,713
| -59% | -$179K | ﹤0.01% | 1618 |
|
|
2016
Q1 | $259K | Buy |
+4,564
| New | +$259K | ﹤0.01% | 1209 |
|
|
2015
Q3 | – | Sell |
-3,686
| Closed | -$1.4M | – | 1318 |
|
|
2015
Q2 | $1.4M | Buy |
+3,686
| New | +$1.4M | 0.03% | 435 |
|